SCHEMBL19124504

SCHEMBL19124504

CN(C)[C@@H]1CCCC[C@H]1N(C)Cc1cc(C(C)(C)C)cc(C(C)(C)C)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.47
TSHR P16473 4/20 0.47
ALDH1A1 P00352 4/20 0.47
GAA P10253 3/20 0.47
MAPK1 P28482 2/20 0.47
HTT P42858 2/20 0.47
XBP1 P17861 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CYP2C19 P33261 8/20 0.47
CYP1A2 P05177 7/20 0.46
CYP2C9 P11712 5/20 0.46
HSD17B10 Q99714 2/20 0.46
HIF1A Q16665 2/20 0.42
LMNA P02545 1/20 0.37
ALOX15 P16050 1/20 0.37
HSPA5 P11021 2/20 0.34
CYP3A4 P08684 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC18A3 Q16572 1/20 0.33
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16440896 1.00 CYP2D6 (0.47) CYP2D6TSHRALDH1A1GAAMAPK1
SCHEMBL19130458 1.00 CYP2D6 (0.47) CYP2D6TSHRALDH1A1GAAMAPK1
SCHEMBL19124267 0.86 CYP2D6 (0.39) CYP2D6TSHRALDH1A1GAAMAPK1
SCHEMBL19124754 0.86 CYP2D6 (0.41) CYP2D6TSHRALDH1A1GAAMAPK1
SCHEMBL19130225 0.85 CYP2D6 (0.37) CYP2D6TSHRALDH1A1GAAMAPK1
SCHEMBL19130228 0.82 CYP2D6 (0.36) CYP2D6TSHRALDH1A1GAAMAPK1
SCHEMBL19130227 0.82 HTT (0.51) CYP2D6TSHRALDH1A1GAAMAPK1
SCHEMBL19130454 0.82 CYP2D6 (0.61) CYP2D6TSHRALDH1A1GAACYP2C19
SCHEMBL19124764 0.81 CA2 (0.41) CYP2D6TSHRNPSR1CYP2C19CYP1A2
SCHEMBL19130239 0.79 CYP2D6 (0.41) CYP2D6TSHRALDH1A1GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines UNIVERSITY COLLEGE DUBLIN (IE) 2019-02-05 US disclosed
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines UNIVERSITY COLLEGE DUBLIN (IE) 2019-02-05 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines ADH1C, ADH1A, ADH5 CYP2D6 1319/4885TSHR 740/4885ALDH1A1 6/4885
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES ADH1C, ADH1A, ADH5 CYP2D6 1401/4885TSHR 614/4885ALDH1A1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.